Gary A Pestano

USPTO Granted Patents = 17 (Patent Applications = 1)

CIPO Patents = 1

EPO Patents = 5 (Patent Applications = 6)

Average Co-Inventor Count = 4.0

ph-index = 5

Forward Citations = 78(Granted Patents)

Location History:

Boulder, CO (US) (2020)
Oro Valley, AZ (US) (2012 - 2021)
Lafayette, CO (US) (2012 - 2023)

Company Filing History:

14 out of 514

Ventana Medical Systems, Inc.

The University of Arizona

patents

4. 2 out of 532

University of Cincinnati

where one patent can have more than one assignee

Years Active: 2012-2023

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11542340 - Antibodies targeting pulmonary nodule specific biomarkers and uses thereof (2023-01-03),

2. 11441189 - Image acquisition methods for simultaneously detecting genetic rearrangement and nuclear morphology (2022-09-13),

3. 10934591 - Grading, staging, and prognosing cancer using osteopontin-c (2021-03-02),

4. 10870891 - Diagnostic test system for specific, sensitive and reproducible detection of circulating nucleic acids in whole blood (2020-12-22),

5. 10422729 - Blood sample separation devices and methods (2019-09-24),

6. 10407736 - Expression of ETS related gene (ERG) and phosphatase and tensin homolog (PTEN) correlates with prostate cancer capsular penetration (2019-09-10),

7. 10082508 - Automated analysis of circulating tumor cells (2018-09-25),

8. 9951388 - Spectral imaging for measurement of nuclear pathology features in cancer cells prepared for in situ analysis (2018-04-24),

9. 9873915 - Grading, staging and prognosing cancer using osteopontin-C (2018-01-23),

10. 9435812 - Expression of ETS related gene (ERG) and phosphatase and tensin homolog (PTEN) correlates with prostate cancer capsular penetration (2016-09-06),

11. 9310302 - Multi-modality contrast and brightfield context rendering for enhanced pathology determination and multi-analyte detection in tissue (2016-04-12),

12. 8798394 - Quantitave, multispectral image analysis of tissue specimens stained with quantum dots (2014-08-05),

13. 8290236 - Quantitative, multispectral image analysis of tissue specimens stained with quantum dots (2012-10-16),

14. 8290235 - Quantitative, multispectral image analysis of tissue specimens stained with quantum dots (2012-10-16),

15. 8285024 - Quantitative, multispectral image analysis of tissue specimens stained with quantum dots (2012-10-09),

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can create an article based on the given data about inventor Gary A Pestano.

Title: Exploring the Innovations of Gary A Pestano

Introduction:

Gary A Pestano, a visionary inventor based in Boulder, CO (US), has made significant contributions to the field of medical research through his groundbreaking patented technologies. With an impressive portfolio of 17 patents, Pestano's work focuses on developing advanced solutions for cancer diagnosis and treatment.

Latest Patents:

Pestano's latest patents showcase his expertise in the medical field:

1. Antibodies targeting pulmonary nodule specific biomarkers and uses thereof: Introducing monoclonal antibodies that bind to specific peptides of C163A or LG3BP, offering innovative compositions and methods for cancer detection and treatment.

2. Image acquisition methods for simultaneously detecting genetic rearrangement and nuclear morphology: A cutting-edge technology for identifying cancer subtypes by analyzing molecular markers and morphological characteristics in biological samples, enhancing the precision of cancer diagnosis.

Career Highlights:

Throughout his career, Pestano has been associated with leading companies in the medical industry, including Ventana Medical Systems, Inc., and Biodesix, Inc. His valuable contributions to these organizations have played a pivotal role in advancing medical research and developing novel healthcare solutions.

Collaborations:

Pestano has collaborated with esteemed colleagues in his field, such as G Scott Lett and Ned C Haubein. Together, they have worked towards revolutionizing cancer diagnostics and improving patient outcomes through innovative technologies.

Conclusion:

In conclusion, Gary A Pestano stands out as a distinguished inventor whose passion for innovation has led to transformative developments in the medical domain. His patents and collaborations bear testimony to his commitment to advancing healthcare through cutting-edge research and technology. Pestano's work continues to inspire and drive progress in the field of cancer diagnosis and treatment.

If you have any further inquiries or need additional information, feel free to ask.

This text is generated by artificial intelligence and may not be accurate.